Single-agent irinotecan as second-line treatment for advanced gastric cancer

Kanat O., Evrensel T., Manavoglu O., Demiray M., Kurt E., Gonullu G., ...More

TUMORI JOURNAL, vol.89, no.4, pp.405-407, 2003 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 89 Issue: 4
  • Publication Date: 2003
  • Doi Number: 10.1177/030089160308900411
  • Journal Name: TUMORI JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.405-407
  • Keywords: gastric cancer, irinotecan, second-line chemotherapy, SUPPORTIVE CARE, PHASE-II, METHOTREXATE, CARBOPLATIN, PACLITAXEL, CISPLATIN
  • Bursa Uludag University Affiliated: Yes


Aim: To investigate the activity and toxicity of irinotecan (CPT-11) as a single agent in patients with advanced gastric cancer after failure of previous 5-fluorouracil-based combination chemotherapy.